🇺🇸 FDA
Patent

US 8048906

Optically pure and enriched isomers of chelating ligands and contrast agents

granted A61KA61K49/085A61K49/10

Quick answer

US patent 8048906 (Optically pure and enriched isomers of chelating ligands and contrast agents) held by Catalyst Medical expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Medical
Grant date
Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K49/085, A61K49/10, A61K49/106, A61K49/14